CIK 0001719406
- Non-accelerated filer
- Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822844431
- Phone
- +1 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-28 | ABRAMS MICHAEL S Chief Financial Officer | Grant or award · Restricted Stock Unit | +75,000 | 75,000 | ||
| 2025-02-07 | ABRAMS MICHAEL S Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 1 of 1 · 2 trades